The moat fact first: Intel's packaging pitch rests heavily on EMIB — its embedded-bridge approach to connecting dies — and protecting that approach is part of its competitive case. US11901299B2, granted February 2024, patents an interconnect architecture combining a silicon interposer with EMIB (CPC H01L 23/5385).
Gloss it once. To connect multiple dies at high density you can use a full silicon interposer (large, expensive) or small embedded bridges placed only where two dies meet (Intel's EMIB). Each has tradeoffs in cost, area, and connection density. Combining them — an interposer plus embedded bridges — is a hybrid that aims to capture the strengths of both.
Why a moat read cares: Intel positions advanced packaging as a reason to use Intel Foundry, and EMIB is the centerpiece of that story. Patents that extend and combine EMIB with other techniques strengthen the IP wall around the differentiator Intel is selling — the part of the pitch that does not depend on winning the transistor race outright.
The period framing matters. In 2024, with Intel pushing its foundry business, packaging differentiation was central to the narrative. A grant combining EMIB and interposer at that moment reflects Intel reinforcing its signature packaging IP exactly when it needed a competitive hook.
The caveat we attach: this is an architecture patent and a defensive asset. It evidences Intel's packaging IP position; it does not quantify cost or performance advantage versus rivals.
For the period investor, the durable point is that Intel's case leans on packaging as much as on logic. A 2024 EMIB-plus-interposer grant is a marker of the moat it is trying to build in the assembly layer.